Nonmalignant Hematology ― Expert Clinical Review: Questions and Answers

This book, in Q&A format, addresses a wide range of clinically relevant topics and issues in non-malignant hematology, or “benign hematology”, with a view to offering a robust, engaging tool that will assist every hematologist and oncologist (pediatric and adult) in making decisions and performing vital activities during daily practice. The entire spectrum of the specialty is covered, including red cell disorders, platelet and coagulation disorders, immune system and related disorders, disorders during pregnancy and in the newborn, surgical aspects, and transfusion medicine. A key aspect of the book is the opportunity it affords expert physicians to express well-reasoned opinions regarding complex issues in hemostasis and thrombosis. Wherever appropriate, guidance is also provided regarding the availability of potentially high-impact clinical trials. Non-malignant Hematology: Expert Review provides a practical and immediately applicable compendium of answers to often complex and vexing issues and concerns. It will appeal to residents, fellows, and more experienced practitioners around the globe.

SyedAbutalib?isAssistant Director of Hematology and Blood and Marrow Hematopoietic?CellTransplant Program. Dr. Abutalib earned his medical degree from Dow MedicalCollege in Karachi, Pakistan and subsequently completed a residency in InternalMedicine at Cook County Hospital and a Fellowship in Hematology/Oncology at theUniversity of Illinois at Chicago. During his Fellowship he participated inLeukemia Research at Northwestern Hospital & University of Chicago. Boardcertified in Internal Medicine, Medical Oncology and Hematology, Dr. Abutalibspecializes in benign hematology, malignant hematology and hematopoietic bloodand marrow cell transplant. Dr. Abutalib has been published in severalpeer-reviewed journals, including the?American Journal of Hematology,?CurrentPharmaceutical Biotechnology,?and the?American Journal ofClinical Pathology?and?has written chapters for medicaltextbooks, including?Acute Leukemias?(2008),?Evidence-BasedHematology(2008),?Expert Hematology & Oncology Essentials?(2014)and?Cancer Consult-Expertise for Clinical Practice?(2014),Essential Oncology (2015). Dr. Abutalib is the editor of several booksincluding,?Cancer Consult-Expertise for Clinical Practice?publishedon behalf of Blackwell Wiley Health Sciences. He?is on the editorial boardfor?Clinical Oncology News?and??THE ASCO POST?magazineand contributes regularly?in the? column " HowI?Manage.." and ?“Expert Hematology Review”,respectively.?Besides his Patients he hold Medical Education dear to hisheart.?

Jean M. Connors?is an Assistant Professor ofMedicine at Harvard Medical School. Dr Connors received her medical degree fromJohns Hopkins University School of Medicine in Baltimore, Maryland. Shecompleted residency in Internal Medicine at Beth Israel Hospital, Boston,Massachusetts, and fellowships in both Hematology/Oncology and TransfusionMedicine at Brigham and Women’s Hospital, Boston. Dr Connors cares for patientswith inherited and acquired thrombotic and coagulation disorders. ?AsMedical Director of the Brigham and Women’s Hospital and Dana Farber CancerInstitute Anticoagulation Management Service, Dr Connors overseesanticoagulation practices in outpatient clinical settings. She is also theMedical Director of the Hemostatic Antithrombotic Stewardship program, amulti-disciplinary care delivery program, to ensure judicious and optimal useof anticoagulants and clotting factors across all BWH inpatient services. Shehas participated in??a variety of types of clinical trials focusingon anticoagulation including investigator initiated, served on scientificadvisory boards for a number of companies, teaches extensively at many levelsincluding peers in CME courses as well as fellows and residents, and haswritten numerous reviews and chapters in the area of thrombosis-hemostasis.

MargaretRagni?is aProfessor of Medicine and Clinical Translational Science?at the Universityof Pittsburgh Medical Center, Pittsburgh, Pennsylvania. She received her MDfrom the University of Pittsburgh School of Medicine and a Master of PublicHealth from the University of Pittsburgh School of Public Health. She completedher residency and fellowship in hematology/oncology at the University ofPittsburgh Medical Center in Pittsburgh, where she joined the faculty in 1983.Dr. Ragni’s research interests are in congenital and acquired disorders ofhemostasis and thrombosis, and, in, particular in novel therapeutics forpatients with hemophilia with and without inhibitors. She serves on the Medicaland Scientific Advisory Committee of the National Hemophilia Foundation (NHF),the FDA Blood Products Advisory Committee, the Scientific Committee onHemostasis of the American Society of Hematology, and on the Medical AdvisoryBoard for the Foundation for Women and Girls with Blood Disorders (FWGBD). Shealso served as Co-Chair for the 2014 ASH Annual Meeting; as Co-Chair of theResearch Committee of the Hemostasis & Thrombosis Research Society, and isa member of the Research Committee of the American Thrombosis & HemostasisNetwork. She is past member of the Hemostasis Thrombosis Study Section of theNHLBI, and Co-Chair of the Bleeding Disorders Subcommittee of the NHLBI Stateof the Science Symposium. She serves on Scientific Advisory Boards for Alnylam,Baxalta, Biogen, and Biomarin. ?She has conducted numerous clinicaltrials, observational studies, retrospective data base analyses,cost-effectiveness analyses, and investigator-initiated new drug trials inhemophilia and von Willebrand disease. She is the medical director of theHemophilia Center of Western PA, providing care for patients with bleeding andclotting disorders, teach and mentor medical students, residents, fellows, andyoung faculty.

?